Patents by Inventor L'Emira Ghida HARFOUCHE

L'Emira Ghida HARFOUCHE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Selective Nox-1 inhibitor peptides and uses thereof
    Patent number: 10517919
    Abstract: The present invention relates to novel peptides, compositions and methods for the prevention and/or treatment of pathological conditions and diseases associated with NADPH oxidase 1 (Nox1) activity, and/or increased reactive oxygen species (ROS) production. The novel peptides are thus particularly useful for treating and/or preventing cancer, atherosclerosis, angiogenesis, and aging.
    Type: Grant
    Filed: August 3, 2017
    Date of Patent: December 31, 2019
    Assignees: Universite de Bordeaux, INSERM
    Inventors: Hamid Reza Rezvani, Frédéric Mazurier, Alain Taieb, L'Emira Ghida Harfouche
  • SELECTIVE NOX-1 INHIBITOR PEPTIDES AND USES THEREOF
    Publication number: 20170340697
    Abstract: The present invention relates to novel peptides, compositions and methods for the prevention and/or treatment of pathological conditions and diseases associated with NADPH oxidase 1 (Nox1) activity, and/or increased reactive oxygen species (ROS) production. The novel peptides are thus particularly useful for treating and/or preventing cancer, atherosclerosis, angiogenesis, and aging.
    Type: Application
    Filed: August 3, 2017
    Publication date: November 30, 2017
    Inventors: Hamid Reza REZVANI, Frédéric MAZURIER, Alain TAIEB, L'Emira Ghida HARFOUCHE
  • SELECTIVE NOX-1 INHIBITOR PEPTIDES AND USES THEREOF
    Publication number: 20170000842
    Abstract: The present invention relates to novel peptides, compositions and methods for the prevention and/or treatment of pathological conditions and diseases associated with NADPH oxidase 1 (Nox1) activity, and/or increased reactive oxygen species (ROS) production. The novel peptides are thus particularly useful for treating and/or preventing cancer, atherosclerosis, angiogenesis, and aging.
    Type: Application
    Filed: January 3, 2014
    Publication date: January 5, 2017
    Inventors: Hamid Reza REZVANI, Frédéric MAZURIER, Alain TAIEB, L'Emira Ghida HARFOUCHE
  • SELECTIVE NOX-1 INHIBITOR PEPTIDES AND USES THEREOF
    Publication number: 20160030503
    Abstract: The present invention relates to novel peptides, compositions and methods for the prevention and/or treatment of pathological conditions and diseases associated with NADPH oxidase 1 (Nox1) activity, and/or increased reactive oxygen species (ROS) production. The novel peptides are thus particularly useful for treating and/or preventing cancer, atherosclerosis, angiogenesis, and aging.
    Type: Application
    Filed: January 3, 2014
    Publication date: February 4, 2016
    Inventors: Hamid Reza REZVANI, Frédéric MAZURIER, Alain TAIEB, L'Emira Ghida HARFOUCHE